Anekal Sreeram, MD
Otolaryngology · Merrillville, INNPI 1659560100
Payments from drug & device makers
Across 42 payments — averaging $59.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$313
- Esperion Therapeutics, Inc.$250
- Boston Scientific$238
- Novo Nordisk$235
- Stryker$178
- EKOS Corporation$168
- plus $1K from 14 others
What the payments were for
- Food & beverage$2,491100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 6 | $313 |
| Esperion Therapeutics, Inc. | 2 | $250 |
| Boston Scientific | 2 | $238 |
| Novo Nordisk | 2 | $235 |
| Stryker | 2 | $178 |
| EKOS Corporation | 2 | $168 |
| Lilly USA, LLC | 1 | $125 |
| Lexicon Pharmaceuticals, Inc. | 1 | $123 |
| Boehringer Ingelheim | 1 | $110 |
| Sanofi | 4 | $103 |
| Johnson & Johnson(2 entities) | 2 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $100 |
| Smith+Nephew | 3 | $100 |
| Medtronic | 4 | $99 |
| Intuitive Surgical | 1 | $98 |
| Merck | 4 | $71 |
| Integra Lifesciences Corporation | 1 | $29 |
| Livanova USA, Inc. | 1 | $22 |
| Acclarent, Inc | 1 | $16 |
| Optinose US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXLIZET$250
- NEXLETOL$250
- Inspire$239
- JARDIANCE$235
- XPRESS ENT DILATION SYSTEM$168
- Ozempic$125
- WATCHMAN Access System$125
- Inpefa$123
- GENERAL ERECTILE DYSFUNCTION$113
- Tresiba$110
- TRULANCE$100
How this compares
$2,491 in reported general payments places this provider in the 60th percentile of 193 otolaryngology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 386 | $5,472 |
| Azelastine Hcl | 65 | $2,139 |
| Meclizine Hcl | 26 | $413 |
| Pantoprazole Sodium | 38 | $310 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 20 | $189 |
| Azithromycin | 65 | $176 |
| Montelukast Sodium | 27 | $108 |
| Chlorhexidine Gluconate | 33 | $90 |
| Levocetirizine Dihydrochloride | 12 | $56 |
| Famotidine | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Merrillville
- Thomas TarinMerrillville$6K
- Ryan CmejrekMerrillville$5K
- Dennis HanMerrillville$4K
- Scott PhillipsCarmel$2.2M
- Joshua GreeneAnderson$1.1M
- Venkata KakarlapudiNew Albany$175K
- Colin NeumannNew Albany$135K
- Noah ParkerCarmel$133K
- Tod HuntleyCarmel$124K
- Satyan SreenathIndianapolis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.